TBC1D16 and neoplasm: Several CpG sites in the gene body of TBC1D16, including the TBC1D16-47KD cryptic promoter, exhibited significant loss of methylation (− 47% on average) in metastatic melanomas (green and magenta boxplots) compared to primary tumours (red boxplots).